Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Inception Therapeutics acts as a biotech "discovery engine," building and launching transformative new biotechnology companies. Since its founding in 2011 with Versant Ventures, it has launched at least seven successful biotech startups addressing unmet medical needs across oncology, nephrology, neurology, immunology, and more. Its integrated scientific capabilities have led to several drugs entering clinical trials or reaching the market through its portfolio companies. The company itself does not run traditional therapeutic pipelines but instead creates new ventures that do so[1][2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Inception Therapeutics.